跳至主要内容
临床试验/NCT01638286
NCT01638286已完成不适用

Study to Evaluate a Pharmacokinetic Drug Interaction Between Eperisone Hydrochloride and Aceclofenac in Healthy Male Subjects

Hanmi Pharmaceutical Company Limited0 个研究点目标入组 24 人开始时间: 2012年8月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

A randomized, open label, single-dose, 6-sequence, 3-period, crossover study to evaluate a pharmacokinetic drug interaction between eperisone hydrochloride and aceclofenac in healthy male subjects.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • BMI : 20.0 - 28.0 kg/m2 willingness to sign the written informed consent form(ICF)

排除标准

  • Evidence of clinically relevant pathology within 30 days prior to drug administration History of relevant drug and/or food allergies

研究者

发起方
Hanmi Pharmaceutical Company Limited
申办方类型
Industry
责任方
Sponsor

相似试验

Study to Evaluate a Pharmacokinetic Drug Interaction... | 临床试验